Advanced Cancer Research: defining a platform for convergent oncology
Peer-Reviewed Publication
Updates every hour. Last Updated: 20-Jun-2026 14:16 ET (20-Jun-2026 18:16 GMT/UTC)
Cancer research is undergoing a profound transformation. Advances in molecular and cellular biology, genomics, immunology, engineering, and computational science have reshaped our understanding of cancer as a complex, multiscale disease. Yet the gap between biological discovery and durable clinical benefit remains a central challenge. Addressing this gap increasingly requires integration across disciplines, technologies, and conceptual frameworks. Advanced Cancer Research is an international, peer-reviewed, open-access journal publishing original cancer research spanning basic, translational, and clinical investigation. The journal prioritizes studies that provide mechanistic depth, introduce conceptual or technological innovation, or offer system-level insight into cancer biology and therapy, with particular emphasis on work that bridges disciplinary boundaries and advances translational relevance.
Insilico Medicine announced its participation in the World Health Expo 2026 (WHX 2026), held from February 9–12 at the Dubai Exhibition Centre,Booth S19J30 (Emirates Health) at South Hall
Researchers at Arizona State University and their international colleagues have developed a device that cuts sample consumption by as much as 97% while still producing high-quality structural data. The technology could accelerate drug discovery by showing how medicines interact with their protein targets in real time and help engineers design better enzymes for industry and biotechnology. It may also enable deeper insights into disease, enable the study of rare proteins that are difficult to produce, and unlock the full potential of next-generation X-ray laser facilities without excessive sample waste.
Babies are born with the ability to predict rhythm, according to a study published February 5th in the open-access journal PLOS Biology by Roberta Bianco from the Italian Institute of Technology, and colleagues.
In a series of tea party-like experiments, Johns Hopkins University researchers demonstrate for the first time that apes can use their imagination and play pretend, an ability thought to be uniquely human.
– Researchers at UC Santa Cruz developed a faster way to screen enzyme variants, helping scientists identify promising drug-making molecules much earlier and easing a major bottleneck in biocatalysis that has slowed pharmaceutical discovery for decades.
– The new method enhances mass spectrometry by capturing molecular shape, not just weight, allowing scientists to distinguish between molecules that weigh the same but behave very differently in the body—an essential capability for safe and effective drug development.
– Using this approach, the team streamlined production of the neurochemical kainic acid, reducing its synthesis from many complex chemical steps to just two, including a single enzyme-driven reaction inspired by seaweed biology.